StemRIM

About:

StemRIM is a bio company that specializes in developing regeneration-inducing medicines.

Website: https://www.stemrim.com

Twitter/X: StemRIM_Inc

Top Investors: SMBC Venture Capital, Mitsubishi UFJ Capital, Mizuho Capital, Shionogi, Nippon Venture Capital

Description:

Stem Rim is a biotechnology company aiming to develop “regenerative medicine”.We are developing drugs based on a new mechanism of action that mobilizes stem cells present in the living body to the injured or diseased tissue without removing them out of the body and induces functional tissue regeneration.

Total Funding Amount:

3.45B JPY

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Osaka, Osaka, Japan

Founded Date:

2006-10-30

Founders:

Katsuto Tamai

Number of Employees:

51-100

Last Funding Date:

2018-12-28

IPO Status:

Public

Industries:

© 2025 bioDAO.ai